These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 3510779

  • 1. Historical perspectives on inotropic agents.
    Farah AE.
    Circulation; 1986 Mar; 73(3 Pt 2):III4-9. PubMed ID: 3510779
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inotropic drugs for treatment of the failing heart.
    Maskin CS, Le Jemtel TH, Sonnenblick EH.
    Cardiovasc Clin; 1984 Mar; 14(3):1-17. PubMed ID: 6327040
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S, Hosokawa T, Kojima M, Mori T, Yabuuchi Y.
    Arzneimittelforschung; 1984 Mar; 34(3A):342-6. PubMed ID: 6331464
    [Abstract] [Full Text] [Related]

  • 7. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR.
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [From Digitalis purpurea to toad skin. An historical view of digitalis-like mammalian hormones ].
    Ritz E, Schoner W.
    Dtsch Med Wochenschr; 2008 Dec; 133(51-52):2690-4. PubMed ID: 19067271
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of amrinone, a new non-digitalic positive inotropic agent, on the efficiency and coronary circulation of the heart].
    Bárcenas L, Kabela E.
    Arch Inst Cardiol Mex; 1984 Dec; 54(5):431-40. PubMed ID: 6517640
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Rational and irrational approach to the inotropic agent therapy of heart failure].
    Colombo F, Libretti A.
    Clin Ter; 1988 Sep 30; 126(6):421-6. PubMed ID: 2974404
    [No Abstract] [Full Text] [Related]

  • 17. Newer inotropic agents.
    Sharpe DN.
    Methods Find Exp Clin Pharmacol; 1984 Apr 30; 6(4):215-8. PubMed ID: 6087050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A tribute to the memory of the illustrious maestro and academic Dr. Rafael Méndez Martínez, pioneer in the pharmacological studies of digitalis and digitalis glycosides].
    de Micheli Serra A, Pastelín Hernández G.
    Gac Med Mex; 2015 Apr 30; 151(5):660-5. PubMed ID: 26526481
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.